{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:50:25Z","timestamp":1782190225091,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Methotrexate (MTX) is a widely used chemotherapeutic and immunosuppressive agent; however, its clinical utility is frequently limited by dose-dependent hepatotoxicity which was mediated through oxidative stress and dysregulated inflammatory signaling. The present study investigated the protective effect of dapansutrile (DAPA), a selective NLRP3 inflammasome inhibitor, against MTX-induced hepatic injury in rats and elucidated the underlying molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MTX hepatotoxicity was induced by a single intraperitoneal injection (20\u00a0mg\/kg), while DAPA was administered orally at doses of 10 or 20\u00a0mg\/kg for seven consecutive days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MTX administration resulted in pronounced liver dysfunction, as evidenced by marked elevations in serum ALT, AST, ALP, and GGT levels, severe histopathological alterations, enhanced lipid peroxidation, depletion of endogenous antioxidants, and activation of TLR4\/MyD88\/NF-\u03baB signaling. Furthermore, MTX robustly triggered NLRP3 inflammasome activation, leading to increased caspase-1 activity, elevated IL-1\u03b2 and IL-18 levels, enhanced gasdermin D cleavage, and induction of pyroptotic cell death. MTX also disrupted hepatic autophagic activity, as indicated by reduced LC3-II levels and p62 accumulation. DAPA treatment significantly ameliorated these biochemical, histological, and molecular abnormalities. DAPA suppressed oxidative stress, attenuated inflammatory cytokine production, inhibited inflammasome-mediated pyroptosis, and restored autophagic balance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, these findings demonstrate that DAPA confers robust hepatoprotection against MTX-induced toxicity through coordinated modulation of inflammatory, oxidative, pyroptotic, and autophagic pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1798557","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:34:38Z","timestamp":1782189278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dapansutrile mitigates methotrexate-induced hepatotoxicity in rats: roles of inflammation, oxidative stress, pyroptosis, and autophagy"],"prefix":"10.3389","volume":"17","author":[{"given":"Haider H.","family":"Motlak","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elshal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]},{"name":"AlGhad College for Applied Medical Sciences","place":["Najran, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.","family":"Serrya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5114\/ceh.2023.132251","article-title":"Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research","volume":"9","author":"Akman","year":"2023","journal-title":"Clin. Exp. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e70606","DOI":"10.1002\/jbt.70606","article-title":"Liraglutide ameliorates methotrexate-induced cardiotoxicity in rats: modulation of oxidative stress, autophagy, and the TNF-\u03b1\/NF-\u039aB signaling inflammatory pathway","volume":"39","author":"Ali","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"115341","DOI":"10.1016\/j.fct.2025.115341","article-title":"Procyanidin B2 mitigates methotrexate-induced hepatic pyroptosis by suppressing TLR4\/NF-\u039aB and Caspase-3\/GSDME pathways","volume":"199","author":"Alsaab","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-\u039aB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"119296","DOI":"10.1016\/j.jep.2024.119296","article-title":"Mangiferin mitigates methotrexate-induced liver injury and suppresses hepatic stellate cells activation in rats: imperative role of Nrf2\/NF-\u039aB\/NLRP3 signaling axis","volume":"340","author":"El-Sayed","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"859383","DOI":"10.1155\/2015\/859383","article-title":"Mechanisms of thymoquinone hepatorenal protection in methotrexate-induced toxicity in rats","volume":"2015","author":"El-Sheikh","year":"2015","journal-title":"Mediat. Inflammation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"152840","DOI":"10.1016\/j.tox.2021.152840","article-title":"Hepatotoxic potentials of methotrexate: understanding the possible toxicological molecular mechanisms","volume":"458","author":"Ezhilarasan","year":"2021","journal-title":"Toxicology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCRESAHA.116.303787","article-title":"Untangling autophagy measurements: all fluxed up","volume":"116","author":"Gottlieb","year":"2015","journal-title":"Circulation Research"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e29518","DOI":"10.7759\/cureus.29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed","year":"2022","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"903834","DOI":"10.3389\/fimmu.2022.903834","article-title":"The NLRP3 inflammasome inhibitor dapansutrile attenuates cyclophosphamide-induced interstitial cystitis","volume":"13","author":"Kiran","year":"2022","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, Proof-of-Concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S302","DOI":"10.3350\/cmh.2022.0329","article-title":"Non-alcoholic fatty liver disease: the pathologist\u2019s perspective","volume":"29","author":"Leow","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1039\/c9fo00114j","article-title":"Ferulic acid protects against methotrexate nephrotoxicity: Via activation of Nrf2\/ARE\/HO-1 signaling and PPAR\u03b3, and suppression of NF-\u039aB\/NLRP3 inflammasome axis","volume":"10","author":"Mahmoud","year":"2019","journal-title":"Food Funct."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E1530-E1539","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-Sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"113752","DOI":"10.1016\/j.biopha.2022.113752","article-title":"Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the TLR4\/NF-\u03baB pathway and NLRP3 inflammasome\/caspase 1 axis","volume":"155","author":"Matouk","year":"2022","journal-title":"Biomed. Pharmacotherapy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biopha.2017.10.113","article-title":"Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats","volume":"97","author":"Mehrzadi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2133\/dmpk.dmpk-10-rv-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Peter Guengerich","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.3390\/biomedicines13123050","article-title":"Canonical NF-\u03baB pathway as a central regulator of obesity-associated inflammation: a narrative review","volume":"13","author":"Petrascu","year":"2025","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1354\/vp.42-4-405","article-title":"Technical aspects of immunohistochemistry","volume":"42","author":"Ramos-Vara","year":"2005","journal-title":"Vet. Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"119123","DOI":"10.1016\/j.lfs.2021.119123","article-title":"BBG enhances OLT1177-Induced NLRP3 inflammasome inactivation by targeting P2X7R\/NLRP3 and MyD88\/NF-\u039aB signaling in DSS-induced colitis in rats","volume":"270","author":"Saber","year":"2021","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15116","DOI":"10.3390\/ijms232315116","article-title":"Methotrexate-induced liver injury is associated with oxidative stress, impaired mitochondrial respiration, and endoplasmic reticulum stress in vitro","volume":"23","author":"Schmidt","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.joca.2005.04.017","article-title":"Expression and regulation of toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes","volume":"13","author":"Su","year":"2005","journal-title":"Osteoarthr. Cartilage"},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1743-7075-11-17","article-title":"Glutamine attenuates the inhibitory effect of methotrexate on TLR signaling during intestinal chemotherapy-induced mucositis in a rat","volume":"11","author":"Sukhotnik","year":"2014","journal-title":"Nutr. Metab. (Lond)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2119\/molmed.2017.00077","article-title":"Inflammasome and autophagy regulation: a two-way street","volume":"23","author":"Sun","year":"2017","journal-title":"Mol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/liv.15811","article-title":"Ferritinophagy-mediated ferroptosis facilitates methotrexate-induced hepatotoxicity by high-mobility group box 1 (HMGB1)","volume":"44","author":"Wang","year":"2024","journal-title":"Liver Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.14336\/AD.2019.0116","article-title":"Pyroptosis in liver disease: new insights into disease mechanisms","volume":"10","author":"Wu","year":"2019","journal-title":"Aging Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/bcpt.13306","article-title":"Reactive oxygen species, not Ca2+, mediates methotrexate-induced autophagy and apoptosis in spermatocyte cell line","volume":"126","author":"Xiong","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1522206","DOI":"10.3389\/fcell.2025.1522206","article-title":"Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2023.05.005","article-title":"Methotrexate use among men\u2014association with fertility and the perinatal health of their children: a Swedish nationwide register study","volume":"120","author":"Zar\u00e9n","year":"2023","journal-title":"Fertil. Steril."},{"key":"B33","doi-asserted-by":"publisher","first-page":"112503","DOI":"10.1016\/j.biopha.2021.112503","article-title":"Clinical implications of chemotherapeutic agent organ toxicity on perioperative care","volume":"146","author":"Zeien","year":"2022","journal-title":"Biomed. Pharmacotherapy"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1798557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:34:44Z","timestamp":1782189284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1798557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":33,"alternative-id":["10.3389\/fphar.2026.1798557"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1798557","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"1798557"}}